SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) ($DOG.X) is trending as community members highlight its fair distribution and status as a Bitcoin-native meme coin launched via Runes. Many see $DOG.X as a way to onboard more users to Bitcoin, emphasizing its strong community and decentralized nature. Some community members are comparing it to $DOGE.X and anticipating a similar parabolic run.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

$BROKE.X is trending as the community celebrates new all-time highs and anticipates an upcoming Bifinance listing. This meme coin on Solana is touted for its strong community, consistent development, and resilience, with many highlighting its 9-month survival in a space where projects often fade quickly. The ongoing 'Biggest Buy Contest' and a locked airdrop are also generating excitement.

DMTC or DIAMOND The Cat Coin is a viral meme coin on Solana Blockchain, Based in Thailand and Global and Based on a true story about my lovely cat(DIAMOND) and made by love, I just want my cat to be immortal in this whole world until I die that's a first idea of this project start. We're start from $2,000 Market cap and hit All time high at $10.9 million, please come to check our project and let's DMTC get list on Coingecko to let's everyone in this whole world know DMTC.

DIAMOND The Cat Coin

DIAMOND The Cat Coin ($DMTC.X) is gaining attention, with community members highlighting accumulation and potential for a breakout. Discussions center on its strong chart and the expectation of significant upward movement, with many using terms like "rocket" and "moon mission" to describe its potential. Community members suggest early entry for optimal gains.

What Is Pi Network? Pi Network is a social cryptocurrency, developer platform, and ecosystem designed for widespread accessibility and real-world utility. It enables users to mine and transact Pi using a mobile-friendly interface while supporting applications built within its blockchain ecosystem.  Supply Model and Mining Mechanism The Maximum Supply of Pi is 100 billion tokens. The Maximum Supply is comprised of the following: 65 Billion tokens (or 65%) are allocated for all community mining rewards; 10 billion (10%) are allocated for foundation reserves; 5 billion (5%) are allocated for liquidity purposes; and 20 billion (20%) are allocated for the Core Team. Each allocation mentioned above tracks the community Migrated Mining Rewards issuance pace, so the proportions of each allocation in the total supply remains the same at any given time.   The Effective Total Supply of Pi—the total Pi supply at the current time—allocates Pi proportionally the same as the Maximum Supply. Since every allocation tracks the Migrated Mining Rewards of the community, the Effective Total Supply can be calculated by dividing the current Migrated Mining Rewards of Pi on the Mainnet blockchain by 65%. The other allocations within the Effective Total Supply can then be calculated based on the same proportions as the Maximum Supply, e.g. at most 10% of the Effective Total Supply is available in the foundation reserve, 5% of the Effective Total Supply is available for liquidity purposes, and 20% of the Effective Total Supply is available for the Core Team. This remains true despite the fact that all tokens were minted at the genesis as technically required by the blockchain protocol.  Circulating Supply includes all Migrated Mining Rewards and all tokens that entered circulation from other buckets of the allocations, which at its maximum could be summed up to equal the Effective Total Supply.   Pi’s mining rewards are distributed based on an issuance formula that follows a declining exponential model defined in the Pi whitepaper. Users can increase the amount of mining rewards they receive based on their individual contributions to the network, like Security Circles, using utility-based Pi apps, running Nodes, etc. For each month, the amount of Pi to be distributed as mobile balance is capped and determined by the model, regardless of how many people or how many types of mining rewards there are during the month. The capping is achieved by the design of a system-wide base mining rate, and each type of mining rewards to each individual are just a multiplier of this base mining rate. As the monthly supplies always diminish, the base mining rate generally decreases over time.   Fewer Pi may also be issued because the real Pi issuance on the blockchain depends on Pioneers passing KYC and completing all steps required for migration to the Mainnet. Despite all efforts to facilitate and remind Pioneers to complete those required steps, there are always dropoffs along the way, resulting in less than all outstanding mobile balances to be issued on the blockchain. Because of this mechanism, the community issued amount (Migrated Mining Rewards) on the blockchain will likely be closer and closer to a line lower than the 65 billion. This is thus the reason for the variable Effective Total Supply which incorporates this effect. Effective Total Supply results from all Migrated Mining Rewards divided by 65%, as opposed to the Maximum Supply of 100 billion.  Ecosystem and Adoption Pi Network has built an integrated ecosystem that facilitates real-world transactions and decentralized applications. Pi can be used as a medium of exchange for goods and services, including online commerce and local brick-and-mortar businesses.  Users can engage with Core Team and community-built apps in the Pi ecosystem through the Pi Browser, where integrated features like the Pi Wallet provide a seamless experience. Events like PiFest 2024 showcased Pi’s growing adoption, with over 27,000 active sellers and 28,000 test merchants across 160 countries.  Who Are the Founders of Pi Network? Pi Network was founded by Dr. Nicolas Kokkalis and Dr. Chengdiao Fan, both of whom have PhDs from Stanford University and a passion for improving human lives through technology.  Dr. Nicolas Kokkalis is a Stanford PhD in EE and postdoc in CS with research on distributed systems and human-computer interaction. His work focuses on combining distributed systems and human computer interaction to bring cryptocurrency to everyday people. As a strong and long-term believer of the technical, financial and social potential of cryptocurrencies, he is determined to move them beyond their current limitations and is committed to bringing the power of blockchain to more people.  Dr. Chengdiao Fan holds a Stanford PhD in Anthropological Sciences, harnessing social computing to unlock human potential on a global scale. Chengdiao is building Pi Network to mobilize individuals all over the world to participate and be rewarded for their contributions, and establish an inclusive ecosystem for global citizens to unleash and capture their own agency, and in turn create utilities and productions for society and the world.  Compliance and Identity Verification Pi Network follows a one-account-per-person policy through its Know Your Customer (KYC) solution. This system combines machine automation and human verification to authenticate user identities while preserving privacy.  The KYC process emphasizes real individuals, combats fraudulent activities and enables fair participation in the mining process of the network. Pi’s identity verification approach balances scalability, security, and accessibility, allowing millions of users worldwide to validate their accounts while maintaining regulatory compliance.

Pi Network

Pi Network is trending as the community discusses the upcoming expiration of the KYC grace period and its potential impact on the circulating supply. Some users express frustration with unverified balances, while others remain optimistic about the project's long-term vision and increasing adoption. Discussions also cover potential listings and new developments within the Pi ecosystem.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is trending as the community discusses the implications of the CEO's upcoming retirement and a newly appointed replacement. Some investors speculate this transition, combined with recent strategic moves like selling European rights, points towards a potential acquisition, while others express concern about the company's future direction. Discussions also focus on the company's earnings potential and pipeline development.

Warner Bros. Discovery, Inc. is a premier global media and entertainment company, which engages in the provision of a differentiated portfolio of content, brands, and franchises across television, film, streaming, and gaming. It operates through the following segments: Studios, Networks, Direct-to-Consumer (DTC), and Corporate. The Studios segment includes producing and releasing feature films for initial exhibition in theaters, producing and initial licensing television programs to networks services as well as third parties, distributing films and television programs to various third party, internal television, and streaming services, distribution through the home entertainment market related consumer products, and themed experience licensing and interactive gaming. The Networks segment focuses on domestic and international television networks. The DTC segment is involved in premium pay-television and streaming services. The company was founded on June 17, 1985 and is headquartered in New York, NY.

Warner Bros. Discovery Inc - Ordinary Shares - Class A

Warner Bros Discovery Inc

WBD is trending amid reports that Paramount Skydance is preparing a majority-cash takeover bid, potentially sparking a bidding war with other major players like Amazon and Netflix. The community is buzzing about the potential deal price, with some hoping for a valuation as high as $40 per share, while others are wary of the company's debt and potential regulatory hurdles. This possible acquisition is viewed as a major move in the streaming landscape, potentially creating a stronger competitor to Netflix and Disney.

ZoraAI agents are designed to take the complexity out of everyday tasks, leaving you with more time and energy to focus on what matters most. With their powerful automation and adaptability, your life and work will become more efficient and effortless. With ZoraAI, you’re in control. The customizable agents feature lets you mix and match your favorite tools and capabilities from different agents to build one that’s perfectly tailored to your needs. Whether you want a multitasking powerhouse or a focused specialist, your personalized agent is designed to work exactly how you want it to—no coding required.

Zoracles

Zoracles ($ZORA.X) is trending as community members discuss recent price action and potential breakout scenarios, while some express concerns about possible pullbacks. The coin's association with social media and content creation on the Base network is also a key talking point. Some users are drawing comparisons to other social media platforms.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy Corp

Constellation Energy is trending due to increasing investor interest in nuclear energy solutions for AI and data centers, with potential government support possibly on the horizon. The community is discussing the company's strategic partnerships and expansion efforts, along with considerations regarding its premium valuation, but several analysts remain bullish on the stock's prospects. Some see it as a way to capitalize on the growing demand for reliable, carbon-free baseload power.

Tempest Therapeutics, Inc. is a clinical-stage oncology company advancing a diverse portfolio of small molecule product candidates containing tumor-targeted and/or immune-mediated mechanisms with the potential to treat a wide range of tumors. The company’s novel programs range from early research to later-stage investigation in a randomized global study in first-line cancer patients. Tempest Therapeutics was founded in 2011 and is headquartered in Brisbane, CA.

Tempest Therapeutics Inc

TPST is trending as investors speculate about a potential buyout, driven by trial updates and a perceived strategic fit with larger pharmaceutical companies. The community is actively discussing potential acquirers like Roche and Bayer, buyout price predictions, and the timing of a possible announcement. Some investors believe a deal is imminent due to the company's financial situation and upcoming deadlines.

Wynn Resorts Ltd. is a holding company, which engages in the design, development, and operation of destination casino resorts. It operates through the following segments: Wynn Palace, Wynn Macau, Las Vegas Operations, Encore Boston Harbor, and Corporate and Other. The company was founded by Stephen Alan Wynn, Elaine P. Wynn, and Kazuo Okada in 2002 and is headquartered in Las Vegas, NV.

Wynn Resorts Ltd.

Wynn Resorts (WYNN) is trending amid discussions around its Q2 2025 revenue and Macau's performance, which continues to be a talking point within the community. Investors are weighing expansion plans, such as the Wynn Al Marjan Island in the UAE, against current revenue. Overall sentiment appears cautiously optimistic, tied to the potential for Macau's recovery and the success of new ventures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's  What You Should Know

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics

Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics Rosalind Franklin University's Helix 51 Incubator Welcomes Monopar Therapeutics PR Newswire NORTH CHICAGO, Ill., Jan...

Up 1,000% in 2024, Wall Street Believes This Growth Stock Can Still Skyrocket

This biotech stock is a promising buy, but it does come with risks.

Monopar Therapeutics Inc. ($MNPR)Shares of Monopar skyrocketed over 350% by mid-day Thursday after the Wilmette, Illinois-based micro-cap biotech announced an agreement with AstraZeneca plc’s ($AZN) Alexion rare disease subsidiary to exclusively in-license the latter’s ALXN-1840.&nbsp;The drug candidate is a Phase 3 asset and is being investigated for treating Wilson disease, a&nbsp; rare and progressive genetic condition in which the body’s pathway for removing excess copper is compromised.&nbsp;The agreement calls upon Monopar paying an upfront cash payment and giving AstraZeneca an equity stake. The smaller biotech is also required to make regulatory and sales milestones-based future payments and royalties on future net sales.<figure class="image"><a href="https://stocktwits.com/symbol/MNPR"><img style="aspect-ratio:628/148;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/mnpr_sentiment_224afae297.png" alt="mnpr-sentiment.png" width="628" height="148"></a><figcaption>MNPR sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>Monopar said it will be responsible for all future development and commercialization activities.&nbsp;Energy Vault Holdings, Inc. ($NRGV)Retail sentiment toward Westlake Village, California-based Energy Vault contrasted the stock move on Thursday. The stock was down over 7% by mid-Thursday despite the lack of any major catalyst.&nbsp;On Monday, Energy Vault, a sustainable, grid-scale energy storage solutions provider, announced an agreement with Australian energy developer Enervest Group for the deployment of a 1,000 MWh battery energy storage in New South Wales, Australia.&nbsp;The stock jumped 25% over the next two sessions before pulling back.<figure class="image"><a href="https://stocktwits.com/symbol/NRGV"><img style="aspect-ratio:638/147;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/nrgv_sentiment_ad5ef0470a.png" alt="nrgv-sentiment.png" width="638" height="147"></a><figcaption>&nbsp;NRGV sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, retail sentiment was ‘extremely bullish’ (97/100) compared to the ‘neutral’ sentiment that prevailed on Wednesday.FREYR Battery, Inc. ($FREY)Luxembourg-headquartered FREYR, which manufactures lithium-ion batteries in its Norwegian facilities, has also found traction with retail investors.&nbsp;The green-energy company’s stock may have received a lift from the news that the European Union Innovation Fund has agreed to award 122 million-euro ($132.05 million) to develop its potential joint venture ‘Cathode Active Material’ manufacturing project in Vaasa, Finland.<figure class="image"><a href="https://stocktwits.com/symbol/FREY"><img style="aspect-ratio:637/145;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/frey_sentiment_6c4bdbd8f7.png" alt="frey-sentiment.png" width="637" height="145"></a><figcaption>FREY sentiment and message volume October 24, 2024, as of 2 pm ET | Source:&nbsp;Stocktwits</figcaption></figure>The retail mood is exceedingly exuberant, with the sentiment score on Stocktwits at 97/100.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/quantumscape-stock-jumps-on-earnings-call-updates/cJ21uofR7Z">QuantumScape Stock Bounces Back After Earnings Call Boost, Tesla Tailwinds: Retail Turns Optimistic</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

These 3 stocks have generated the most bullish sentiment among retailers Thursday afternoon.

Monopar Therapeutics, Energy Vault Holdings, FREYR Battery: 3 Stocks Retailers Are Most Bullish Thursday Afternoon

A micro-cap, clinical-stage biotech and two battery manufacturers elicited the most bullish reaction from retail traders.

Equity

A micro-cap, clinical-stage biotech and two battery manufacturers elicited the most bullish reaction from retail traders.


Monopar Therapeutics Stock Jumps 4X, Inks Licensing Pact With AstraZeneca For Once Terminated Phase 3 Candidate For Rare Genetic Disorder

Monopar secures an exclusive license from AstraZeneca's Alexion for ALXN-1840, aiming to advance treatment for Wilson's disease, a rare genetic disorder.
read more...

Shares of Monopar Therapeutics, Inc. (<a class="mention" data-mention="$MNPR" data-symbol-id="MNPR" href="https://stocktwits.com/symbol/MNPR" target="_blank">$MNPR</a>) soared over 500% on Thursday following a major licensing agreement with AstraZeneca (<a class="mention" data-mention="$AZN" data-symbol-id="AZN" href="https://stocktwits.com/symbol/AZN" target="_blank">$AZN</a>) unit Alexion.&nbsp;The stock hit its highest levels since March 2021 and became the top gainer across U.S. exchanges, with retail sentiment surging into ‘extremely bullish’ territory.Monopar secured the rights to ALXN-1840, an oral treatment for Wilson’s disease, a rare genetic disorder that leads to toxic copper build-up in organs.&nbsp;The company will be responsible for all future global development and commercialization activities.In exchange, Monopar will pay an upfront sum in cash and equity, along with future royalties and milestone payments.&nbsp;Under Alexion’s prior development, ALXN-1840 had already met its primary endpoint in a Phase 3 clinical trial.On Stocktwits, retail sentiment for MNPR jumped to ‘extremely bullish’ (97/100), the highest score this year, driven by a surge in message volume as investors reacted to the breakthrough deal.&nbsp;<stembedurl>https://stocktwits.com/Krystian_v/message/589991504</stembedurl><stembedurl>https://stocktwits.com/Mosconi/message/589994892</stembedurl>Monpar stated that its MD, Co-Founder, and CEO, Chandler Robinson, previously conducted laboratory research on tetrathiomolybdate, published his findings in Science, and helped launch the company behind what became ALXN-1840. The focus was on Wilson disease.Wilson’s disease affects around 1 in 30,000 people in the U.S., causing excess copper to accumulate in the liver, brain, and other organs.&nbsp;The disease can lead to liver failure, neurological symptoms, and psychiatric issues, with many cases suffering irreversible damage.MNPR stock has now surged over 1,500% year-to-date.For updates and corrections email <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/lilm-stock-crashes-after-insolvency-warning/cJ21sAxR7k">Air-Taxi Firm Lilium’s Stock Nosedives On Insolvency Warning: Retail Mood Darkens</a>

Monopar secured the rights to ALXN-1840, an oral treatment for Wilson’s disease, a rare genetic disorder that leads to toxic copper build-up in organs.

Monopar Stock Skyrockets After Agreement With AstraZeneca's Unit On Wilson's Disease Drug: Retail On Cloud Nine

The company will be responsible for all future global development and commercialization activities.

Monopar Stock Skyrockets After Agreement With AstraZeneca’s Unit On Wilson's Disease Drug: Retail On Cloud Nine

The company will be responsible for all future global development and commercialization activities.


Why Monopar Therapeutics (MNPR) Stock Is Skyrocketing Today

Monopar Therapeutics shares are trading higher by 108% Thursday morning. The company announced early Phase 1 trial data confirming MNPR-101-Zr's tumor-targeting ability in humans.
read more...

Monopar Therapeutics Inc: Positioned for Growth with Strategic Radiopharmaceutical Pivot and Promising Preclinical Data

JonesTrading analyst Justin Walsh reiterated a Buy rating on Monopar Therapeutics Inc (MNPR Research Report) today and set a price target of $2.0...

Monopar Therapeutics Begins Pioneering MNPR-101-Zr Trial

The latest announcement is out from Monopar Therapeutics Inc (MNPR). Monopar Therapeutics Inc. has reached a pivotal milestone by enrolling the fir...

Monopar Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying

Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.

MNPR
Monopar Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MNPR News

MNPR Monopar Therapeutics Inc